Isotis/GenSci
This article was originally published in The Gray Sheet
Executive Summary
Pre-merger licensing pact allows firms to move ahead with platform integration, giving IsoTis access to GenSci technology related to its demineralized bone matrix reverse-phase medium (RPM) carrier system. IsoTis will combine the RPM carrier system with its lead OsSatura synthetic bone substitute technology for dental and maxillofacial reconstruction. A June 3 merger deal is expected to close this fall (1"The Gray Sheet" June 9, 2003, p. 26)...